The Lancet· 2017

Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study

Hashim U. Ahmed, Ahmed El‐Shater Bosaily, Louise Brown, Rhian Gabe et al.

3,248citations
2017year

Short summary

Multi-parametric MRI (MP-MRI) is more sensitive (93%) than TRUS-biopsy (48%) for detecting clinically significant prostate cancer, potentially allowing 27% of men to avoid unnecessary biopsies.

AI-generated from the title and abstract; the full text is not read.

TakeawaysIn the app

Key pointsIn the app

Ask the paperIn the app

The rest is in the Pofolia app

Takeaways, key points and questions to the paper; new summaries every day for your field. Free.

Get it on Google Play Download on the App Store

Field: Pulmonary and Respiratory Medicine

Pulmonary and Respiratory MedicineMedicine